Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Fluid: Debt repayment efforts are underway and will continue until 100% of affected users’ funds are covered.

Fluid: Debt repayment efforts are underway and will continue until 100% of affected users’ funds are covered.

ForesightNewsForesightNews2026/03/25 02:11
Show original

According to Foresight News, the DeFi protocol Fluid posted on Twitter regarding the "Resolv Labs attack incident," stating that its debt repayment work is currently ongoing and will continue until 100% of affected users’ funds are covered.


The official statement indicates that approximately 70 million USD of USR-related debt on BNB Chain and Plasma chains has been repaid, and the remaining debt will be settled over the next few days. A governance proposal has already been published on-chain, aiming to transfer the remaining USR debt positions to the team's multi-signature address for further settlement with the Resolv team. A compensation plan for all affected USR users will be announced as soon as possible.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Just about three months after listing, two SK Hynix leveraged ETFs are set to be delisted in the United States.

Tradr ETFs announced that its two leveraged products linked to SK Hynix ADRs will be liquidated and delisted around November 12, with one being long and the other short. Despite only being listed for a few months, their combined scale has shrunk to about $1.3 million, down more than 60% from their peak. SK Hynix's Seoul stock price has fallen 56% from its high, similar products in the industry are generally under pressure, and South Korea has also further tightened regulations on leveraged products.

华尔街见闻•2026/10/26 05:56
Just about three months after listing, two SK Hynix leveraged ETFs are set to be delisted in the United States.

A $5 billion single-product emerges? JPMorgan maintains a "Neutral" rating on Amgen (AMGN.US): A good drug doesn't necessarily mean a good buying opportunity.

Amgen's Imdelltra has maintained data with an HR of 0.42, nearly doubling survival time. Morgan Stanley estimates that it will become a single product with annual sales of around 5 billions USD. However, they maintain a Neutral rating and a target price of 350 USD.

智通财经•2026/10/26 04:20
A $5 billion single-product emerges? JPMorgan maintains a "Neutral" rating on Amgen (AMGN.US): A good drug doesn't necessarily mean a good buying opportunity.